[Excerpt] Research tools, a subset of biotechnological inventions protected by process patents, are “tools that scientists use in the laboratory, including cell lines, monoclonal antibodies, reagents, animal models, growth factors, combinatorial chemistry and DNA libraries, clones and cloning tools (such as PCR), methods, laboratory equipment and machines.” Many companies base their business models on the ability to find pharmaceutical products using their proprietary drug discovery research tools. Research tools used for drug discovery ‘include bioinformatic methods for identifying the interaction of certain proteins and their association with disease, methods for confirming protein targets, screening assays to identify molecules active a...
Over the last two decades changes in technology and policy have altered the landscape of drug discov...
Author Institution: Department of Dairy Science, Laboratories of Molecular and Developmental Biology...
Institutional devices encouraging biotechnological innovation may not be providing adequate returns ...
The continued development of and affordable access to potentially life saving pharmaceuticals, gene ...
The continued development of and affordable access to potentially life saving pharmaceuticals, gene ...
The recent decision by Judge Sweet in Association for Molecular Pathology, et al. v. U.S. Patent and...
Support for new drug development has taken some interesting turns in current patent law jurisprudenc...
As recombinant DNA technology has evolved into a prominent tool to synthesize new products in the ph...
This paper discusses the requirements for patentability as applied to biotechnology and pharmaceutic...
The authors review administrative and court decisions prompting proposed changes to the patent law. ...
Merck sought protection under a statutory exemption from claims of patent infringement brought by In...
Through out the decades, biotechnology has emerged as research area which requires the understanding...
Biotechnology companies and research institutions have patented thousands of genes based on the idea...
[Excerpt] “Recent advances in biotechnology are expected by many to improve crop yield, reduce relia...
Microbial technologies often serve as the basis of fundamental research tools in molecular biology. ...
Over the last two decades changes in technology and policy have altered the landscape of drug discov...
Author Institution: Department of Dairy Science, Laboratories of Molecular and Developmental Biology...
Institutional devices encouraging biotechnological innovation may not be providing adequate returns ...
The continued development of and affordable access to potentially life saving pharmaceuticals, gene ...
The continued development of and affordable access to potentially life saving pharmaceuticals, gene ...
The recent decision by Judge Sweet in Association for Molecular Pathology, et al. v. U.S. Patent and...
Support for new drug development has taken some interesting turns in current patent law jurisprudenc...
As recombinant DNA technology has evolved into a prominent tool to synthesize new products in the ph...
This paper discusses the requirements for patentability as applied to biotechnology and pharmaceutic...
The authors review administrative and court decisions prompting proposed changes to the patent law. ...
Merck sought protection under a statutory exemption from claims of patent infringement brought by In...
Through out the decades, biotechnology has emerged as research area which requires the understanding...
Biotechnology companies and research institutions have patented thousands of genes based on the idea...
[Excerpt] “Recent advances in biotechnology are expected by many to improve crop yield, reduce relia...
Microbial technologies often serve as the basis of fundamental research tools in molecular biology. ...
Over the last two decades changes in technology and policy have altered the landscape of drug discov...
Author Institution: Department of Dairy Science, Laboratories of Molecular and Developmental Biology...
Institutional devices encouraging biotechnological innovation may not be providing adequate returns ...